SCHEMBL14699424

SCHEMBL14699424

Cn1cc(-c2cc(Cl)nn2C2CCCCO2)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.40
CYP4A11 Q02928 2/20 0.40
RET P07949 7/20 0.39
CREBBP Q92793 2/20 0.38
PIK3CD O00329 1/20 0.37
FLT3 P36888 1/20 0.35
SYK P43405 1/20 0.35
AURKB Q96GD4 1/20 0.35
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
WNT1 P04628 1/20 0.35
GSK3B P49841 1/20 0.35
DYRK1A Q13627 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
AXL P30530 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
ACVRL1 P37023 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14699428 0.83 IRAK4 (0.39) CYP4F2CYP4A11RETPIK3CDFLT3
SCHEMBL15795733 0.77 TYRO3 (0.43) AXL
SCHEMBL14689981 0.74 SCD (0.39) CYP4F2CYP4A11RETCREBBPFLT3
SCHEMBL15795983 0.74 KDM5B (0.40) CYP4F2CYP4A11CREBBPFLT3SYK
SCHEMBL18437194 0.71 GSK3B (0.45) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL31725423 0.71 RXRA (0.64) RXRARXRBRXRGWNT1GSK3B
SCHEMBL14688722 0.71 PIM1 (0.45) CYP4F2CYP4A11CREBBPFLT3SYK
SCHEMBL24809147 0.70 AXL (0.46) CYP4F2CYP4A11CREBBPFLT3SYK
SCHEMBL14689334 0.70 PIM1 (0.49) CREBBP
SCHEMBL14688644 0.67 PIM1 (0.49) CREBBPAXLIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2742046-A1 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE F.HOFFMANN-LA ROCHE AG (CH) 2014-06-18 EP disclosed
WO-2013024002-A1 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2013-02-21 WO disclosed